States used a number of Medicaid emergency authorities to address the COVID-19 public health emergency. Between March 2020 and July 2021 we tracked details on Medicaid Disaster Relief State Plan Amendments (SPAs), other Medicaid and CHIP SPAs, and other state-reported administrative actions; Section 1115 Waivers; Section 1135 Waivers; and 1915 (c) Waiver Appendix K strategies. This resource was last updated July 1, 2021 and is no longer being updated.
- view as grid
- view as list
This post looks at a new contactless method of providing medication abortions and now this can be and has been used in response to the pandemic. The post also examines state policies that act as barriers to implementing these new protocols.
This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.
As the coronavirus pandemic kept people home last year, just over 1 in 4 Medicare beneficiaries had a telehealth visit with a doctor or other health professional between the summer and fall of 2020, a new KFF analysis finds. Once limited to beneficiaries living in rural areas, coverage of telehealth…
This brief provides an overview of changes in coverage of telehealth under traditional Medicare before the coronavirus pandemic, and estimates changes in use of telehealth services using survey data from the Medicare Current Beneficiary Survey (MCBS) during the pandemic. The analysis also discusses issues and questions related to extending telehealth coverage under traditional Medicare beyond the public health emergency.
This issue brief provides a deeper look at telecontraception platforms, offering insights into the practices of 13 different companies that have attempted to make contraception more accessible outside of a clinical setting.
Women’s Sexual and Reproductive Health Services: Key Findings from the 2020 KFF Women’s Health Survey
This brief presents new data from the KFF Women’s Health Survey on coverage and use of reproductive and sexual health services among different subgroups of women ages 18 to 49.
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries, including questions related to out-of-pocket costs, the COVID-19 vaccine, telehealth, extended supplies of medication, skilled nursing facility stays, and issues for people in private Medicare Advantage plans.
A new KFF survey of obstetrician-gynecologists (OBGYNs) offers insight into how the coronavirus pandemic has affected the provision of sexual and reproductive health care, including the growth of telehealth and the ongoing challenges and limitations of such medical visits. Key findings from the survey, which was conducted from July to…